These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1062 related articles for article (PubMed ID: 21890816)
1. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M; Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816 [TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851 [TBL] [Abstract][Full Text] [Related]
3. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Fischbach W; Goebeler ME; Ruskone-Fourmestraux A; Wündisch T; Neubauer A; Raderer M; Savio A; Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089 [TBL] [Abstract][Full Text] [Related]
4. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856 [TBL] [Abstract][Full Text] [Related]
5. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. Andriani A; Miedico A; Tedeschi L; Patti C; Di Raimondo F; Leone M; Schinocca L; Romanelli A; Bonanno G; Linea C; Giustini M; Hassan C; Cottone M; Zullo A Dig Liver Dis; 2009 Jul; 41(7):467-73. PubMed ID: 18945654 [TBL] [Abstract][Full Text] [Related]
6. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369 [TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928 [TBL] [Abstract][Full Text] [Related]
8. Long-term results of stomach-conserving therapy in gastric MALT lymphoma. Vrieling C; de Jong D; Boot H; de Boer JP; Wegman F; Aleman BM Radiother Oncol; 2008 Jun; 87(3):405-11. PubMed ID: 18343513 [TBL] [Abstract][Full Text] [Related]
9. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis. Al-Taie O; Al-Taie E; Fischbach W Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome. Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046 [TBL] [Abstract][Full Text] [Related]
11. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases. Begum S; Sano T; Endo H; Kawamata H; Urakami Y J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978 [TBL] [Abstract][Full Text] [Related]
12. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379 [TBL] [Abstract][Full Text] [Related]
14. Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy. Fischbach W; Dorlöchter C Z Gastroenterol; 2019 May; 57(5):593-599. PubMed ID: 31083747 [TBL] [Abstract][Full Text] [Related]
15. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M Oncology; 2004; 66(6):476-80. PubMed ID: 15452377 [TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. Wündisch T; Thiede C; Morgner A; Dempfle A; Günther A; Liu H; Ye H; Du MQ; Kim TD; Bayerdörffer E; Stolte M; Neubauer A J Clin Oncol; 2005 Nov; 23(31):8018-24. PubMed ID: 16204012 [TBL] [Abstract][Full Text] [Related]